BrainXell, Inc.
Biotechnology company · Madison, Wisconsin, United States
BrainXell, Inc. is a biotechnology company headquartered in Madison, Wisconsin, United States. It has received 8 US government small-business research awards (SBIR/STTR) from health agencies, $4.2 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2021.
BrainXell at a glance
What does BrainXell do?
US government research funding
8 SBIR/STTR small-business research awards from US health agencies, $4.2 million in total (2016 to 2023). NIH funding came from the National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $13.2 million sold (2021).
Frequently asked questions about BrainXell
Where is BrainXell headquartered?
BrainXell, Inc. is headquartered in Madison, Wisconsin, United States.
What does BrainXell do?
BrainXell, Inc. is a biotechnology company.
Similar companies
- Flugen IncMadison, Wisconsin, United States
- Stemina Biomarker Discovery, Inc.Madison, Wisconsin, United States
- Cellular Logistics, Inc.Madison, Wisconsin, United States
- Capio Biosciences, Inc.Madison, Wisconsin, United States
- Dianomi Therapeutics, Inc.Madison, Wisconsin, United States
- Protegera, Inc.Madison, Wisconsin, United States
- Semba Biosciences IncMadison, Wisconsin, United States
- Scarab Genomics LLCMadison, Wisconsin, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences